Tokyo Tape
Sign in
← Baby calendar

Annual report

7363.TEDINET S100T87U
Period2023-01-01 → 2023-12-31
Filed2024-04-05
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amends S100T6QY. Amended by S100T88F (2024-04-05).

Key figures · 84
MetricValuePeriodScopeSource row
Revenue¥1.2bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥1.1bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥1.0bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥894m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥600m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥31m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥38m2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥27m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥37m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥116m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥96m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥33m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥45m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥37m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥101m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥21m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥75m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥62m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥71m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.0bnat 2023-12-31StandaloneAssets
Total assets¥1.1bnat 2022-12-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥502mat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥373mat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥311mat 2023-12-31StandaloneLiabilities
Total liabilities¥324mat 2022-12-31StandaloneLiabilities
Net assets / equity¥706mat 2023-12-31StandaloneNet assets
Net assets / equity¥806mat 2022-12-31StandaloneNet assets
Net assets / equity¥872mat 2021-12-31dStandaloneNet assets
Net assets / equity¥346mat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥284mat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥357mat 2023-12-31StandaloneCash and deposits
Cash and deposits¥716mat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥357mat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥716mat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥237mat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥173mat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥14m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥3m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥96m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥148m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥68m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥290m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥134m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥17m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥78m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥55m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥189m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥726m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥17m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥45m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-111.482023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥22.942022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥87.662021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.392020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥98.42019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥22.42022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥78.912021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥783.1at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥893.39at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥955.38at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥465.52at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥382.13at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio69.4%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.3%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.2%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio68.8%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio76.0%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE2.5%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE12.3%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE19.6%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE31.9%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued941,700at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued941,700at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued912,200at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued743,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,486at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees71at 2023-12-31StandaloneNumber of employees
Employees56at 2022-12-31StandaloneNumber of employees
Employees49at 2021-12-31dStandaloneNumber of employees
Employees45at 2020-12-31dStandaloneNumber of employees
Employees31at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2023-01-01 → 2023-12-31¥3m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2023-01-01 → 2023-12-31¥7m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentemployeesat 2023-12-3122 pure
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2023-01-01 → 2023-12-31¥299m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2023-01-01 → 2023-12-31¥299m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2023-12-31¥69m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2023-01-01 → 2023-12-31¥17m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2023-01-01 → 2023-12-31¥167m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2023-01-01 → 2023-12-31¥33m
Media Business For Pregnancy Childbirth And Childcarereportable segmentemployeesat 2023-12-3139 pure
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2023-01-01 → 2023-12-31¥904m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2023-01-01 → 2023-12-31¥904m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2023-12-31¥393m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2023-01-01 → 2023-12-31¥197m
Total Of Reportable Segments And Otherssegment totalcapex2023-01-01 → 2023-12-31¥170m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-01-01 → 2023-12-31¥40m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-12-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-12-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-12-31¥463m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-12-31¥214m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2022-01-01 → 2022-12-31¥6m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2022-01-01 → 2022-12-31¥9m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2022-01-01 → 2022-12-31¥285m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2022-01-01 → 2022-12-31¥285m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2022-12-31¥85m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2022-01-01 → 2022-12-31¥21m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2022-01-01 → 2022-12-31¥113m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2022-01-01 → 2022-12-31¥11m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2022-01-01 → 2022-12-31¥800m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2022-01-01 → 2022-12-31¥800m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2022-12-31¥244m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2022-01-01 → 2022-12-31¥207m
Total Of Reportable Segments And Otherssegment totalcapex2022-01-01 → 2022-12-31¥119m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-01-01 → 2022-12-31¥20m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-12-31¥329m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-12-31¥227m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 875
ItemContextValueUnit
Number of shares heldCurrentYearInstant_No11MajorShareholdersMember10000
Shareholding ratioCurrentYearInstant_No11MajorShareholdersMember0.0110
Number of shares heldCurrentYearInstant_No12MajorShareholdersMember10000
Shareholding ratioCurrentYearInstant_No12MajorShareholdersMember0.0110
Number of shares heldCurrentYearInstant563100
Shareholding ratioCurrentYearInstant0.6245
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember40000
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember900000
Number of voting rights issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember9000
Number of shares issued shares voting rightsCurrentYearInstant_SharesLessThanOneUnitMember1700
Number of shares issued shares voting rightsCurrentYearInstant941700
Number of voting rights issued shares voting rightsCurrentYearInstant9000
Number of shares held in own name treasury shares etcCurrentYearInstant_Row1Member40000
Number of shares held in others names treasury shares etcCurrentYearInstant_Row1Member－
Total number of shares held treasury shares etcCurrentYearInstant_Row1Member40000
Shareholding ratio treasury shares etcCurrentYearInstant_Row1Member0.0425
Number of shares held in own name treasury shares etcCurrentYearInstant40000
Number of shares held in others names treasury shares etcCurrentYearInstant－
Total number of shares held treasury shares etcCurrentYearInstant40000
Shareholding ratio treasury shares etcCurrentYearInstant0.0425
Number of male directors and other officersFilingDateInstant7
Number of female directors and other officersFilingDateInstant1
Ratio of female directors and other officersFilingDateInstant0.125
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000YasudaKeijiMember201500
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000FukushimaTomoharuMember21500
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000TakebayashiYoshiharuMember100
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000SasakiKazuyukiMember1500
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000TakahashiShizuyoMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000KuroiwaDaisukeMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000MineoAkihiraMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000KatayamaTomohiroMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant224600
Audit fees reporting companyPrior1YearDuration20000000JPY
Non audit fees reporting companyPrior1YearDuration－JPY
Audit fees reporting companyCurrentYearDuration22000000JPY
Non audit fees reporting companyCurrentYearDuration－JPY
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember53238000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember53238000JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember5
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass